Cargando…
Genome Editing-Enabled HTS Assays Expand Drug Target Pathways for Charcot–Marie–Tooth Disease
[Image: see text] Copy number variation resulting in excess PMP22 protein causes the peripheral neuropathy Charcot–Marie–Tooth disease, type 1A. To broadly interrogate chemically sensitive transcriptional pathways controlling PMP22 protein levels, we used the targeting precision of TALEN-mediated ge...
Autores principales: | Inglese, James, Dranchak, Patricia, Moran, John J., Jang, Sung-Wook, Srinivasan, Rajini, Santiago, Yolanda, Zhang, Lei, Guha, Rajarshi, Martinez, Natalia, MacArthur, Ryan, Cost, Gregory J., Svaren, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical
Society
2014
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4245164/ https://www.ncbi.nlm.nih.gov/pubmed/25188731 http://dx.doi.org/10.1021/cb5005492 |
Ejemplares similares
-
Myelin protein zero mutations and the unfolded protein response in Charcot Marie Tooth disease type 1B
por: Bai, Yunhong, et al.
Publicado: (2018) -
Noncompaction Cardiomyopathy with Charcot-Marie-Tooth Disease
por: Eltawansy, Sherif Ali, et al.
Publicado: (2015) -
Diagnosis of Charcot-Marie-Tooth Disease
por: Banchs, Isabel, et al.
Publicado: (2009) -
The Expanding Genetic Landscape of Charcot-Marie-Tooth Diseases (CMTs): An Indian Perspective
por: Sanghani, Nirav
Publicado: (2022) -
Post-transcriptional microRNA repression of PMP22 dose in severe Charcot-Marie-Tooth disease type 1
por: Pipis, Menelaos, et al.
Publicado: (2023)